Skip to main content

Table 5 Treatment outcomes for different categories of patients on short and long course regimens (n = 16943)

From: DOTS improves treatment outcomes and service coverage for tuberculosis in South Ethiopia: a retrospective trend analysis

 

New cases

    
 

PTB+ (%)

PTB- (%)

EPTB (%)

Relapse (%)

After default (%)

After failure (%)

Transferred in (%)

Patients on SCC

       

Treatment success

2166 (65)

475 (37)

436 (48)

62 (66)

49 (46)

65 (53)

79 (64)

Default*

726 (22)

483 (37)

320 (36)

13 (14)

45 (42)

31 (25)

33 (26)

Failure

25 (0.7)

-

-

2 (2)

1 (1)

6 (5)

3 (2)

Death

117 (3.5)

72 (5)

24 (3)

11 (12)

5 (5)

2 (1)

2 (2)

Transferred out

306 (9)

269 (21)

118 (13)

6 (6)

7 (7)

18 (15)

7 (6)

Patients on LCC

       

Treatment success

1986 (51)

772 (39)

1932 (42)

14 (56)

32 (25)

11 (61)

189 (59)

Default*

1365 (35)

972 (48)

1922 (42)

8 (33)

79 (61)

2 (11)

24 (8)

Failure

66 (2)

-

-

1 (4)

2 (2)

3 (17)

1 (0.3)

Death

107 (3)

57 (3)

37 (1)

2 (8)

2 (2)

1 (5)

7 (2)

Transferred out

350 (9)

204 (10)

697 (15)

-

14 (11)

1 (6)

3 (1)

  1. * Patients with missing treatment outcome information were assumed to have defaulted and analysed as defaulters.
  2. PTB+ = smear positive pulmonary tuberculosis; PTB- = smear negative pulmonary tuberculosis; EPTB = extra-pulmonary tuberculosis
  3. SCC = short course chemotherapy (2 months on RHZ+/- E or S, followed by 6 months on EH or RH)
  4. LCC = long course chemotherapy (2 months on EH +/-S, followed by 10 months on EH; TH had also been used as an alternative to EH until its recent withdrawal).
  5. R = Rifampicin,; H = Isoniazid; Z = Pyrazinamide; E = Ethambutol; S = Streptomycin; T = Thioacetazone.
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us